Profile submitted by Penny Gilbert
Penny specialises in litigation and advisory work relating to intellectual property rights particularly in the pharmaceutical and biotechnology fields. Her background in the life sciences has led to her acting in patent litigation for pharmaceutical multinationals and for biotech companies including, for example, HGS/GSK, Biogen, Kymab, Chiron/Novartis, Elan, Napp and Affymetrix. She has also acted in litigation and arbitrations over disputed technology contracts, including patent licences. She is experienced in co-ordinating multi-jurisdictional litigation, has represented clients in European Patent Office opposition proceedings and advises on freedom-to-operate issues. Penny is also a qualified mediator and a solicitor advocate.
Member of AIPPI; LSLA; IPLA and President of EPLAW.
Brasenose College, Oxford (1982 MA Biochemistry, 1986 DPhil Molecular Biology); Bristol University (Diploma in IP Law); Qualified Bristows 1991; Partner, Bristows 1998-2007; Partner, Powell Gilbert LLP 2007.
Writes and lectures extensively on IP and Bio/Pharma issues; editoral board of BioScience Law Review and LSIPR.